Description: Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for cancer pain; Buprenorphine Transdermal Patch for chronic pain; and Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders, In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; Tiandixin used as an adjuvant therapy for malignant tumors, hydrothorax and ascites, and respiratory infections; Yitaida for acute promyelocytic leukemia and liver cancer; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; and Beitangning, a pioglitazone hydrochloride capsule to control blood glucose. Further, it offers Nuosen for acute upper digestive tract hemorrhage; Sailimai for the treatment of diarrhea; Apleek Transdermal Patch for contraception; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; and Fengshiye for patients who have pains in bones, joints, and limbs. The company distributes and sells pharmaceutical drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.
Home Page: www.luye.cn
No. 15 Chuang Ye Road
Yantai,
264003
China
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Dian Bo Liu | Co-Founder, Exec. Chairman, CEO and Head of Corp. Directions & Strategies |
| Mr. Rong Bing Yang | Co-Founder & Vice Exec. Chairman |
| Mr. Hui Xian Yuan | Co-Founder & Exec. Director |
| Ms. Yuan Yuan Zhu | Exec. Director |
| Mr. Yuan Chong Liu | Chief Financial Officer |
| Ms. Yun Li Xue | Sr. VP & GM of Shandong Luye |
| Dr. You Xin Li | Head of R&D and Sr. VP |
| Ms. Mei Yi Lee ACIS, ACS, FCIS, FCS | Company Sec. |
| Mr. Zhi Cheng Fan | Chief Engineer of Shandong Luye Pharmaceutical Co Ltd |
| Li Ping Loh | Assistant Company Sec. |
Exchange: HK
Country: HK : Hong Kong
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 20.6186 |
|---|---|
| Trailing PE: | 11.3225 |
| Price-to-Book MRQ: | 1.2436 |
| Price-to-Sales TTM: | 2.4503 |
| IPO Date: | 2004-05-05 |
| Fiscal Year End: | December |
| Full Time Employees: | 4800 |